The AAFP at all times, supports the proper testing of new drugs and biological agents for safety and benefit as measured by health outcomes of value to patients. The Academy supports legislation to protect the public from dangerous products. It believes this protection must be balanced against the need to promote the research, innovation, production, and distribution of useful new pharmaceutical agents. Previously approved agents should be available for research or scientifically supported clinical use for "off label" indications.
The final determination as to the selection of appropirate pharmaceutical agents in the treatment of an individual is best decided by the clinician and the individual patient. (1977) (2013 COD)
Share this page
Alert: Message field is required.
You must sign in before you can share a page on AAFP connection.
Drug Testing and Selection